JP2020502121A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502121A5 JP2020502121A5 JP2019531750A JP2019531750A JP2020502121A5 JP 2020502121 A5 JP2020502121 A5 JP 2020502121A5 JP 2019531750 A JP2019531750 A JP 2019531750A JP 2019531750 A JP2019531750 A JP 2019531750A JP 2020502121 A5 JP2020502121 A5 JP 2020502121A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- vasodilator
- particles
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022197348A JP2023036678A (ja) | 2016-12-14 | 2022-12-09 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
| JP2025019782A JP2025065408A (ja) | 2016-12-14 | 2025-02-10 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662434185P | 2016-12-14 | 2016-12-14 | |
| US62/434,185 | 2016-12-14 | ||
| PCT/US2017/066519 WO2018112258A1 (en) | 2016-12-14 | 2017-12-14 | Methods and compositions for treatment of pulmonary hypertension and other lung disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022197348A Division JP2023036678A (ja) | 2016-12-14 | 2022-12-09 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020502121A JP2020502121A (ja) | 2020-01-23 |
| JP2020502121A5 true JP2020502121A5 (https=) | 2021-01-28 |
Family
ID=60888760
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531750A Pending JP2020502121A (ja) | 2016-12-14 | 2017-12-14 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
| JP2022197348A Pending JP2023036678A (ja) | 2016-12-14 | 2022-12-09 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
| JP2025019782A Pending JP2025065408A (ja) | 2016-12-14 | 2025-02-10 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022197348A Pending JP2023036678A (ja) | 2016-12-14 | 2022-12-09 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
| JP2025019782A Pending JP2025065408A (ja) | 2016-12-14 | 2025-02-10 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US10912778B2 (https=) |
| EP (2) | EP4620525A3 (https=) |
| JP (3) | JP2020502121A (https=) |
| CN (1) | CN110381951A (https=) |
| AU (3) | AU2017378409A1 (https=) |
| BR (1) | BR112019012251A2 (https=) |
| CA (1) | CA3046025A1 (https=) |
| MX (1) | MX2019006938A (https=) |
| RU (1) | RU2019121646A (https=) |
| WO (1) | WO2018112258A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2882258T3 (es) | 2012-12-21 | 2021-12-01 | Mayo Found Medical Education & Res | Métodos y materiales para tratar estenosis de la válvula aórtica calcificada |
| IL262720B2 (en) | 2016-05-05 | 2024-06-01 | Liquidia Tech Inc | Dry powder treprostinil for the treatment of pulmonary hypertension |
| MX2019006938A (es) | 2016-12-14 | 2019-09-06 | Respira Therapeutics Inc | Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon. |
| WO2018132371A2 (en) * | 2017-01-10 | 2018-07-19 | United Therapeutics Corporation | Methods and compositions for treating pulmonary hypertension |
| KR20210150495A (ko) | 2019-04-10 | 2021-12-10 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | 심혈관 기능장애의 성별-의존적 치료를 위한 방법 및 재료 |
| CA3142758A1 (en) * | 2019-06-10 | 2020-12-17 | Respira Therapeutics,Inc. | Carrier-based formulations and related methods |
| CN112569210B (zh) * | 2019-09-27 | 2023-09-15 | 盈科瑞（天津）创新医药研究有限公司 | 一种吸入用马昔腾坦溶液及其制备方法 |
| CN112773898A (zh) * | 2019-11-11 | 2021-05-11 | 广州华真医药科技有限公司 | 磷酸二酯酶5抑制剂在制备抗纤维化疾病药物中的应用 |
| CN110946826B (zh) * | 2019-12-12 | 2022-02-22 | 烟台大学 | 一种利奥西呱口服制剂及其制备方法 |
| BR112022019274A2 (pt) | 2020-03-31 | 2022-11-16 | Softhale Nv | Entrega de aerossol de pelo menos duas composições líquidas |
| US11013688B1 (en) * | 2020-05-28 | 2021-05-25 | Softhale Nv | Methods of treatment of viral diseases |
| WO2022094100A1 (en) * | 2020-10-28 | 2022-05-05 | Insmed Incorporated | Dry powder compositions of treprostinil prodrugs and methods of use thereof |
| US20250000873A1 (en) * | 2021-09-10 | 2025-01-02 | Justus-Liebig-Universitaet Giessen | Inhaled iloprost for rescue treatment and treatment as needed in pulmonary hypertension |
| WO2024249775A2 (en) * | 2023-05-31 | 2024-12-05 | Respira Therapeutics, Inc. | Methods for treatment of pulmonary hypertension |
| CN116687888A (zh) * | 2023-06-02 | 2023-09-05 | 苏州易合医药有限公司 | 伐地那非和达泊西汀复方干粉吸入制剂及其制备方法 |
| CN121714543A (zh) * | 2024-09-23 | 2026-03-24 | 上海欣药智能科技有限公司 | 一种可吸入的含可溶性鸟苷酸环化酶受体激动剂的药物组合物及其用途 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1493685A (en) | 1970-12-15 | 1977-11-30 | May & Baker Ltd | 8-azapurinones |
| GB1338235A (en) | 1970-12-15 | 1973-11-21 | May & Baker Ltd | Azapurinones |
| US4883810A (en) | 1976-08-17 | 1989-11-28 | Burroughs Wellcome Co. | Ethers |
| US4306075A (en) | 1980-03-28 | 1981-12-15 | The Upjohn Company | Composition and process |
| JPS58124778A (ja) | 1982-01-20 | 1983-07-25 | Toray Ind Inc | ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体 |
| DE3417638A1 (de) | 1984-05-10 | 1985-11-14 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur bestimmung geringer stoffmengen von arzneimitteln, von koerpereigenen oder anderen chemischen substanzen in biologischem material |
| US5250534A (en) | 1990-06-20 | 1993-10-05 | Pfizer Inc. | Pyrazolopyrimidinone antianginal agents |
| GB9401090D0 (en) | 1994-01-21 | 1994-03-16 | Glaxo Lab Sa | Chemical compounds |
| GB9514464D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US6441245B1 (en) | 1997-10-24 | 2002-08-27 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
| CA2395558C (en) | 1997-11-12 | 2007-07-17 | Bayer Aktiengesellschaft | Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
| US6521212B1 (en) | 1999-03-18 | 2003-02-18 | United Therapeutics Corporation | Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation |
| US6943166B1 (en) | 1999-04-30 | 2005-09-13 | Lilly Icos Llc. | Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction |
| PT1200090E (pt) | 1999-08-03 | 2013-11-25 | Icos Corp | Formulação farmacêutica à base de um beta-carbolina e seu uso para tratar a disfunção sexual. |
| US6821975B1 (en) | 1999-08-03 | 2004-11-23 | Lilly Icos Llc | Beta-carboline drug products |
| CN1374953A (zh) | 1999-09-16 | 2002-10-16 | 田边制药株式会社 | 含氮的6－员芳香环化合物 |
| CN1264574C (zh) | 2000-09-06 | 2006-07-19 | 田边制药株式会社 | 口服制剂 |
| IL157009A0 (en) | 2001-03-28 | 2004-02-08 | Pfizer | N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| TWI316055B (https=) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
| US20040077624A1 (en) | 2002-05-23 | 2004-04-22 | Pfizer Inc. | Novel combination |
| CA2536293A1 (en) * | 2003-08-22 | 2005-03-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods of treating copd and pulmonary hypertension |
| CA2612917A1 (en) | 2005-06-23 | 2007-01-04 | Schering Corporation | Rapidly absorbing oral formulations of pde5 inhibitors |
| CN101410119B (zh) | 2006-02-03 | 2012-03-07 | 埃科特莱茵单一股份公司 | 依前列醇制剂及其制备方法 |
| EP2026816B1 (en) | 2006-05-15 | 2018-10-24 | United Therapeutics Corporation | Treprostinil administration using a metered dose inhaler |
| CN101903324B (zh) | 2007-12-17 | 2013-07-03 | 联合治疗公司 | 一种制备Remodulin中的活性成分曲前列素的改良方法 |
| EP2237788A4 (en) | 2007-12-27 | 2013-06-05 | Aires Pharmaceuticals Inc | COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF |
| WO2009117095A1 (en) | 2008-03-18 | 2009-09-24 | Arena Pharmaceuticals, Inc. | Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| WO2009115235A1 (en) | 2008-03-20 | 2009-09-24 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of pulmonary hypertension |
| JP5764061B2 (ja) | 2008-08-13 | 2015-08-12 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | マシテンタン含有治療用組成物 |
| LT2447254T (lt) | 2009-06-26 | 2018-01-10 | Nippon Shinyaku Co., Ltd. | Kristalai |
| WO2011030351A2 (en) | 2009-09-03 | 2011-03-17 | Rubicon Research Private Limited | Taste - masked pharmaceutical compositions |
| WO2011037613A1 (en) | 2009-09-23 | 2011-03-31 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of pgi2 receptor agonists |
| ES2611187T3 (es) * | 2010-03-15 | 2017-05-05 | United Therapeutics Corporation | Tratamiento para hipertensión pulmonar |
| BR112012028153A2 (pt) | 2010-05-03 | 2018-08-07 | Tsh Biopharm Corporation Ltd | composição farmacêutica e método para o tratamento de hipertensão |
| PT2593452T (pt) | 2010-07-14 | 2017-04-24 | Novartis Ag | Compostos heterocíclicos agonistas do receptor ip |
| WO2012030645A1 (en) | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
| US10463815B2 (en) | 2012-02-21 | 2019-11-05 | Respira Therapeutics, Inc. | Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents |
| WO2014067699A1 (en) | 2012-10-31 | 2014-05-08 | Activaero Gmbh | Administration of aerosolised iloprost |
| US20160317542A1 (en) | 2013-12-09 | 2016-11-03 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
| WO2015127258A2 (en) | 2014-02-21 | 2015-08-27 | Respira Therapeutics, Inc. | Powder inhaler, system and methods |
| CN107427698A (zh) * | 2015-01-13 | 2017-12-01 | 维瓦斯公司 | 肺高血压的组合疗法 |
| MX2019006938A (es) | 2016-12-14 | 2019-09-06 | Respira Therapeutics Inc | Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon. |
-
2017
- 2017-12-14 MX MX2019006938A patent/MX2019006938A/es unknown
- 2017-12-14 RU RU2019121646A patent/RU2019121646A/ru unknown
- 2017-12-14 AU AU2017378409A patent/AU2017378409A1/en not_active Abandoned
- 2017-12-14 JP JP2019531750A patent/JP2020502121A/ja active Pending
- 2017-12-14 BR BR112019012251-6A patent/BR112019012251A2/pt unknown
- 2017-12-14 CA CA3046025A patent/CA3046025A1/en active Pending
- 2017-12-14 WO PCT/US2017/066519 patent/WO2018112258A1/en not_active Ceased
- 2017-12-14 EP EP25178206.6A patent/EP4620525A3/en active Pending
- 2017-12-14 US US16/469,524 patent/US10912778B2/en active Active
- 2017-12-14 CN CN201780086527.2A patent/CN110381951A/zh active Pending
- 2017-12-14 EP EP17823002.5A patent/EP3554507A1/en not_active Ceased
-
2021
- 2021-01-11 US US17/146,173 patent/US11491160B2/en active Active
- 2021-11-23 US US17/534,282 patent/US11491161B2/en active Active
-
2022
- 2022-06-29 US US17/853,005 patent/US12263174B2/en active Active
- 2022-10-17 AU AU2022256085A patent/AU2022256085A1/en not_active Abandoned
- 2022-12-09 JP JP2022197348A patent/JP2023036678A/ja active Pending
-
2025
- 2025-02-10 JP JP2025019782A patent/JP2025065408A/ja active Pending
- 2025-02-26 US US19/064,180 patent/US20250195531A1/en active Pending
- 2025-11-03 AU AU2025260006A patent/AU2025260006A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502121A5 (https=) | ||
| RU2019121646A (ru) | Способы и композиции для лечения легочной гипертензии и других заболеваний легких | |
| JP6669808B2 (ja) | 超低密度肺粉剤 | |
| US6921528B2 (en) | Highly efficient delivery of a large therapeutic mass aerosol | |
| JP2023036678A5 (https=) | ||
| JP2017513648A (ja) | ニコチン粉末吸入器 | |
| JP7277490B2 (ja) | 肺送達用ラパマイシン粉末 | |
| TW200938232A (en) | Novel dosage and formulation | |
| JP2016519160A (ja) | ３つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム | |
| HK1200343A1 (en) | An inhalable medicament comprising tiotropium | |
| TW202342035A (zh) | 醫藥乾粉吸入配製物 | |
| JP2025501309A (ja) | 心肺障害の治療 | |
| ES2371601T3 (es) | Composición para inhalación. | |
| EP2821061B1 (en) | Novel inhalation formulations | |
| EP2957553A1 (en) | Pharmaceutical formulations of vilanterol | |
| EP2957552B1 (en) | Vilanterol formulations | |
| EP4472609A1 (en) | Inhaled imatinib for treatment of pulmonary hypertension | |
| CN116600790A (zh) | 治疗肺纤维化的方法和组合物 | |
| EP2957551B1 (en) | Dry powder formulations comprising vilanterol | |
| JP2017530988A (ja) | チオトロピウム、アミノ酸及び酸を含有する製剤、並びにその方法 | |
| KR20250169548A (ko) | 분무 건조 트레프로스티닐 제형 | |
| Son et al. | Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. Pharmaceutics 2021, 13, 1528 | |
| CN121714543A (zh) | 一种可吸入的含可溶性鸟苷酸环化酶受体激动剂的药物组合物及其用途 | |
| EP2957550A1 (en) | Pharmaceutical formulations comprising vilanterol | |
| JP2013177429A (ja) | 吸入組成物 |